UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
18.82
-0.12 (-0.63%)
At close: Apr 2, 2026, 4:00 PM EDT
18.82
0.00 (0.00%)
After-hours: Apr 2, 2026, 4:10 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $916.2 million as of April 2, 2026. Its market cap has increased by 72.38% in one year.
Market Cap
916.20M
Enterprise Value
925.83M
1-Year Change
72.38%
Ranking
Category
Stock Price
$18.82
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $916.20M, an increase of 403.68%. That is a compound annual growth rate of 19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 922.00M | -15.90% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 881.00M |
| Arbutus Biopharma | 877.70M |
| Xencor | 873.46M |
| Phathom Pharmaceuticals | 870.73M |
| GH Research | 860.97M |
| Cullinan Therapeutics | 857.05M |
| Fortrea Holdings | 844.31M |
| MapLight Therapeutics | 836.46M |